Accessibility Menu
Fresenius SE & Co logo

Fresenius SE & Co

(OTC) FSNUY

Current Price$10.51
Market Cap$23.68B
Since IPO (2011)+64%
5 Year-14%
1 Year-13%
1 Month-10%

Fresenius SE & Co Financials at a Glance

Market Cap

$23.68B

Revenue (TTM)

€23.07B

Net Income (TTM)

€1.47B

EPS (TTM)

$0.76

P/E Ratio

13.89

Dividend

$0.30

Beta (Volatility)

0.56 (Low)

Price

$10.51

Volume

137,909

Open

$10.50

Previous Close

$10.51

Daily Range

$10.40 - $10.59

52-Week Range

$10.33 - $33.93

FSNUY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Fresenius SE & Co

Industry

Healthcare Providers and Services

Employees

177,783

CEO

Michael Sen, MBA

Headquarters

Bad Homburg vor der Höhe, 61352, DE

FSNUY Financials

Key Financial Metrics (TTM)

Gross Margin

25%

Operating Margin

9%

Net Income Margin

6%

Return on Equity

8%

Return on Capital

7%

Return on Assets

3%

Earnings Yield

7.20%

Dividend Yield

2.90%

Payout Ratio

46.33%

Stock Overview

Market Cap

$23.68B

Shares Outstanding

2.25B

Volume

137.91K

Avg. Volume

146.94K

Financials (TTM)

Gross Profit

€5.47B

Operating Income

€2.09B

EBITDA

€3.17B

Operating Cash Flow

€2.59B

Capital Expenditure

-€1.44B

Free Cash Flow

€1.15B

Cash & ST Invst.

€1.58B

Total Debt

€11.93B

Fresenius SE & Co Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

€5.91B

+4.7%

Gross Profit

€1.56B

+10.6%

Gross Margin

26.38%

N/A

Market Cap

$23.68B

N/A

Market Cap/Employee

$135.15K

N/A

Employees

175,202

N/A

Net Income

€442.15M

+93.1%

EBITDA

€916.83M

-3.4%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

-€9.86B

+11.2%

Accounts Receivable

€5.69B

+10.1%

Inventory

€2.73B

+3.7%

Long Term Debt

€9.55B

-16.2%

Short Term Debt

€2.37B

+6.0%

Return on Assets

3.47%

N/A

Return on Invested Capital

6.63%

N/A

Free Cash Flow

€161.61M

+231.4%

Operating Cash Flow

€411.66M

+635.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
FMCQFFresenius Medical Care AG & Co. KGaA
$45.17+0.00%
CSLLYCSL Limited
$16.35-1.68%
ESLOYEssilorLuxottica S.A.
$98.24-0.92%
ESLOFEssilorLuxottica S.A.
$201.48+2.73%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$16.73-0.01%
IBITiShares Bitcoin Trust
$37.00-0.03%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$37.19+0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$86.56-0.01%

Questions About FSNUY

What is the current price of Fresenius SE & Co?

Fresenius SE & Co is trading at $10.51 per share.

What is the 52-week range for Fresenius SE & Co?

Over the past 52 weeks, Fresenius SE & Co has traded between $10.33 and $33.93.

How much debt does Fresenius SE & Co have?

As of the most recent reporting period, Fresenius SE & Co reported total debt of €13.72B.

How much cash does Fresenius SE & Co have on hand?

Fresenius SE & Co reported €2.37B in cash and cash equivalents in its most recent financial results.

What is Fresenius SE & Co’s dividend yield?

Fresenius SE & Co currently has a dividend yield of 2.90%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.